Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:20 2024-04-30 am EDT 5-day change 1st Jan Change
149 EUR -0.67% Intraday chart for Merck KGaA +0.85% +3.37%
Sales 2024 * 21.24B 22.66B Sales 2025 * 22.51B 24B Capitalization 64.76B 69.06B
Net income 2024 * 2.97B 3.17B Net income 2025 * 3.49B 3.72B EV / Sales 2024 * 3.37 x
Net Debt 2024 * 6.79B 7.24B Net Debt 2025 * 4.83B 5.15B EV / Sales 2025 * 3.09 x
P/E ratio 2024 *
21.8 x
P/E ratio 2025 *
18.5 x
Employees 62,908
Yield 2024 *
1.55%
Yield 2025 *
1.63%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Merck KGaA

1 day-0.67%
1 week+0.85%
Current month-8.95%
1 month-8.95%
3 months-3.09%
6 months+4.16%
Current year+3.37%
More quotes
1 week
148.10
Extreme 148.1
155.60
1 month
142.70
Extreme 142.7
163.60
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
59.38
Extreme 59.375
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 67 19-04-25
Director/Board Member 62 90-12-31
More insiders
Date Price Change Volume
24-04-30 149 -0.67% 246,131
24-04-29 150 -1.19% 185,338
24-04-26 151.8 +1.10% 282,863
24-04-25 150.1 -1.48% 259,860
24-04-24 152.4 -0.85% 339,364

Delayed Quote Xetra, April 30, 2024 at 11:35 am EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
149 EUR
Average target price
182 EUR
Spread / Average Target
+22.19%
Consensus